In addition to print materials, Immunize.org periodically records live webinars and produces or shares short educational videos related to immunization. These webinars and videos reflect current information at the time they were recorded.
During this session, features of the News & Updates section were navigated. Coverage of the weekly IZ Express newsletter, What’s New on Immunize.org, the Official Release Repository of vaccine-related announcements from ACIP, CDC, and FDA, and the Calendar of Events all provide healthcare professionals with current news and recommendations about vaccines and vaccine-preventable diseases.
This session demonstrates the navigation of publication archives, vaccine timeline, and information about our organization.
This session guides navigation through the Ask the Experts web section, sharing tips for obtaining fast, accurate search results. Immunize.org’s well-qualified and experienced Ask the Experts team provides answers to over 1,300 practical, vaccine-related clinical questions.
This session reviewed Official Guidance: Healthcare Professional Organizations and demonstrated content available under recommended schedules and vaccine recommendations.
Dr. Moore discusses the importance of influenza vaccination for healthcare professionals to protect themselves and their patients from disease.
Dr. Moore discusses the impact of influenza illness over recent seasons. Children are the most likely age group to catch influenza, but complications, hospitalizations, and death can occur at any age. Increased influenza vaccination could prevent substantial numbers of hospitalizations and deaths.
Dr. Kelly Moore discusses when infants and toddlers should receive RSV preventive antibody products
Dr. Kelly Moore shares how effective Beyfortus and Enflonsia (RSV preventive antibody products) are in preventing hospitalizations among infants.
Dr. Kelly Moore responds to the question, can you benefit from the influenza vaccine if you already had the flu this season?
Several vaccines on the CDC’s childhood immunization schedule were reclassified from a routine recommendation to a shared clinical decision-making recommendation in January 2026. Dr. Moore discusses what that means for how vaccines are offered to patients.
Dr. Kelly Moore discusses what should be done if an infant is inadvertently given RSV vaccine instead of an RSV preventive antibody.
Dr. Kelly Moore answers the question “What proof do I need before giving the COVID-19 vaccine to a patient who states they are significantly immunocompromised?”
Dr. Kelly Moore describes how different COVID-19 vaccines train the immune system to recognize parts of the spike protein found on the surface of the SARS-CoV-2 virus.
Dr. Kelly Moore responds to the question, “When giving COVID-19 vaccine is use of a Vaccine Information Statement, known as a VIS, required?”
Dr. Kelly Moore answers the question: Are COVID-19 vaccines helpful during pregnancy?
Dr. Kelly Moore shares why it is especially important to vaccinate the mom during pregnancy and that influenza vaccination can occur during any trimester.
Dr. Kelly Moore shares how important it is to vaccinate babies against rotavirus. She also discusses the significant impact the vaccine has had by reducing the number of physician visits, emergency department visits, and hospitalizations.
Dr. Kelly Moore discusses which adults should be administered hepatitis B vaccine.
Learn more about LetsGetRealAboutVaccines.org, a trustworthy, parent-friendly site originally developed and launched in 2024 as a project of the Department of Health and Human Services and transferred to Immunize.org in early 2025. This site equips families and healthcare providers to confidently support childhood immunization. Share this site with healthcare providers or anyone seeking credible information about childhood vaccines. The entire website is also available in Spanish.
In this video, Kelly Moore, MD, MPH, president and CEO of Immunize.org, reviews the areas of the Immunize.org website that present vaccine schedules and recommendations published by healthcare professional organizations.
Authoritative international travel vaccination information is available on Immunize.org and VaccineInformation.org
This session explores the content found within the Vaccines A-Z website section. This section is organized by vaccine/disease and includes links to vaccine-specific material found under Clinical Resources, Ask the Experts, Official Guidance (recommendations, package inserts, state policies), Travel, Unprotected People Stories, and Photos and Videos.
This session demonstrates navigation of the Travel Vaccines section on Immunize.org and VaccineInformation.org
This session demonstrates how to navigate Immunize.org’s Clinical Resources website section. With almost 200 vaccine-related printable resources, we support immunizing healthcare professionals with up-to-date and accurate materials. Many patient resources have been translated and are available in other languages. All resources are free to download, print, and share.
This session demonstrates how to navigate Immunize.org’s Vaccine Information Statements (VIS) website section, including how to access hundreds of translations of VISs in dozens of languages.
Dr. Kelly Moore answers Bexero schedule questions, “Why did FDA change the dosing schedule for Bexsero brand of meningococcal B vaccine (made by GSK) in August 2024? Do I need to recall my patients who received Bexsero under the old schedule?”
Dr. Kelly Moore responds to this question, “Are high-dose influenza vaccine or the adjuvanted influenza vaccine recommended for anyone younger than age 65?”
This session demonstrates navigating resources found under Official Guidance: States. Content covers states’ school immunization and exemption requirements, state immunization websites, and key public health contact information.
Dr. Kelly Moore answers the question, “My patient is 80 and had a dose of pneumococcal polysaccharide vaccine, abbreviated PPSV23, at age 65. He has never had a pneumococcal conjugate vaccine (or PCV). What is due now?”
Dr. Kelly Moore responds to this question “My patient just turned 50 and has never had a pneumococcal vaccine. What are my options now?”
Dr. Kelly Moore answers the question, “Will people vaccinated at age 50 need additional doses of pneumococcal conjugate vaccine, or “PCV,” in the future?”
This session explores the website, LetsGetRealAboutVaccines.org. This newly launched website provides credible, plain-language information about routine pediatric vaccines, including scientific and safety references. The website in English and Spanish includes videos and visual communication to increase accessibility and understanding of vaccines.
Dr. Kelly Moore responds to an inquiry “My family practice office has both RSV vaccine and the RSV preventive antibody product for infants left over at the end of RSV season. Should we discard them after the end of the season, as we do influenza vaccines?”
Dr. Kelly Moore discusses “Some children in my practice started the pneumococcal vaccine series with the 13-valent pneumococcal conjugate vaccine, PCV13. Now that PCV15 or PCV20 are recommended, do I need to restart the vaccination series or give additional vaccine doses to all of them?”
Dr. Kelly Moore discusses “How do we account for the history of receipt of Prevnar (the original 7-valent pneumococcal conjugate vaccine) when determining the pneumococcal vaccination needs of an older teen or adult with a high-risk condition?”
Dr. Kelly Moore answers “What is pneumococcal serotype 4 and when might it be considered when selecting a pneumococcal conjugate vaccine product for adults?”
Dr. Kelly Moore answers the question, “Why did ACIP shift the age for routine pneumococcal conjugate vaccination of all adults from 65 years down to 50 years in October 2024?”
Dr. Kelly Moore reminds viewers to ensure pediatricians know about maternal RSV vaccination status
This session demonstrates the navigation and highlights of five affiliated websites of Immunize.org: VaccineInformation.org, ImmunizationCoalitions.org, Influenza-Defense.org, Give2MenACWY.org, and Mass-Vaccination-Resources.org.
Should we give the RSV preventive antibody product to an infant who is younger than 8 months of age in October but whose mother received Abrysvo RSV vaccine during pregnancy with this infant last winter?
Dr. Moore discusses protecting infants from RSV by administering RSV vaccine during pregnancy or giving RSV preventive antibody product to the infant after birth.
Dr. Kelly Moore answers the question, “Can I give RSV vaccine to someone who is at 36 weeks and 5 days’ gestation?”
Dr. Kelly Moore answers the question, “Why did ACIP change its RSV vaccination recommendations for older adults in 2024 to remove the option for vaccination of healthy people 60 through 74 who would like to be vaccinated?”
Dr. Kelly Moore answers, “Is RSV vaccine an annual vaccination, like influenza?”
Dr. Kelly Moore discusses the assessment of need for RSV vaccination in healthy adults under age 75
Our experts show you how to navigate Immunize.org and use available tools in a series of Website Office Hours webinars. View recorded sessions or attend live monthly sessions.
Dr. Kelly Moore answers the question, I have a 69-year-old patient who requested RSV vaccination. He has controlled hypertension and no other underlying medical conditions. Is RSV vaccination indicated?
The Travel Vaccines main page connects you with authoritative travelers’ health information, with a focus on vaccination, from CDC and other expert sources.
Learn more about Immunize.org’s vaccine-specific pages.
Learn about resources related to state immunization requirements for childcare, school, and college entry.
Dr. Kelly Moore explores content found under the News & Updates tab: Current and archived issues of our weekly publication, IZ Express; updates made to the Immunize.org website, Official Release Repository of immunization-related announcements from ACIP, CDC, FDA, the website’s Calendar of Events highlighting national meetings, and Publication Archives of historical publications from Immunization Action Coalition.
Dr. Kelly Moore explores content found under the News & Updates tab: Current and archived issues of our weekly publication, IZ Express; updates made to the Immunize.org website, Official Release Repository of immunization-related announcements from ACIP, CDC, FDA, the website’s Calendar of Events highlighting national meetings, and Publication Archives of historical publications from Immunization Action Coalition.
Learn about federal Vaccine Information Statements (VISs) and the hundreds of VIS translations available at Immunize.org.
Learn how to locate what you need among the more than 200 resources we offer to support your immunization practice.
Dr. Kelly Moore answers the question, “What are the high-risk conditions specified by ACIP as indications for RSV vaccination among adults age 60 through 74 years?”
Dr. Kelly Moore answers the question,” Can any of the three licensed RSV vaccines be used during pregnancy?”
Our experts show you how to navigate Immunize.org and use available tools in a series of Website Office Hours webinars. View recorded sessions or attend live monthly sessions.
Kelly Moore answers the question: How often should the RSV vaccine be given?
This session demonstrates navigation of the Travel Vaccines section and explores the content covered within the Vaccine Confidence & Addressing Concerns section of Immunize.org.
Recommendations for the use of human papillomavirus (HPV) vaccine.
Dr. Kelly Moore answers the question, “What is respiratory syncytial virus (RSV)?”
Learn about resources related to state immunization requirements for childcare, school, and college entry.
Learn more about Immunize.org’s vaccine-specific pages.
